Evidence map›Paper›PMID 28043969›Full record

ReviewAlcohol and alcoholism (Oxford, Oxfordshire)2017

The Role of NFkB in Drug Addiction: Beyond Inflammation.

S E Nennig, J R Schank

Abstract readReview
In one paragraph

Review in Alcohol and alcoholism (Oxford, Oxfordshire), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 98 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
98citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

98 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Protective Effects ofInternational journal of molecular sciences · 2025
    Article
  10. Article
  11. Article
  12. Review
  13. Therapeutic effects ofFrontiers in pharmacology · 2025
    Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Anti-Neuroinflammatory Effects ofInternational journal of molecular sciences · 2024
    Article
  20. Article

38 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

S E NennigDepartment of Physiology and Pharmacology, University of Georgia, 501 D.W. Brooks Drive, Athens, GA 30602, USA.
J R SchankDepartment of Physiology and Pharmacology, University of Georgia, 501 D.W. Brooks Drive, Athens, GA 30602, USA.

Funding

The Role of the Neurokinin-1 Receptor and NF kappa B in alcohol-induced behaviorR00AA021805 · NIAAA · UNIVERSITY OF GEORGIA · PI SCHANK, JESSE R · 2014 to 2016
$724k
6 · The paper itself

Abstract

aimsNuclear factor kappa light chain enhancer of activated B cells (NFkB) is a ubiquitous transcription factor well known for its role in the innate immune response. As such, NFkB is a transcriptional activator of inflammatory mediators such as cytokines. It has recently been demonstrated that alcohol and other drugs of abuse can induce NFkB activity and cytokine expression in the brain. A number of reviews have been published highlighting this effect of alcohol, and have linked increased NFkB function to neuroimmune-stimulated toxicity. However, in this review we focus on the potentially non-immune functions of NFkB as possible links between NFkB and addiction.

methodsAn extensive review of the literature via Pubmed searches was used to assess the current state of the field.

resultsNFkB can induce the expression of a diverse set of gene targets besides inflammatory mediators, some of which are involved in addictive processes, such as opioid receptors and neuropeptides. NFkB mediates complex behaviors including learning and memory, stress responses, anhedonia and drug reward, processes that may lie outside the role of NFkB in the classic neuroimmune response.

conclusionsFuture studies should focus on these non-immune functions of NFkB signaling and their association with addiction-related processes.

Indexed as

Gene Expression RegulationAnhedoniaBehavior, AddictiveHumansInflammationLearningMemoryNeuropeptidesNF-kappa BReceptors, OpioidSubstance-Related DisordersNeuropeptidesNF-kappa BReceptors, Opioid

Identifiers

PMID28043969
PMCPMC6410896

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.